Related Experiment Video
Updated: Jun 23, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
An interlaced IMRT technique for elongated tumor volumes
Jürgen Meyer1, Anne Richter, Leo Pfreundner
1Department of Physics and Astronomy, University of Canterbury, Christchurch, New Zealand.
Summary
A new dual isocenter technique for intensity modulated radiotherapy (IMRT) allows treatment of large targets using the multileaf collimator (MLC). This interlaced method is robust, clinically applicable, and achieves dose distributions equivalent to more complex approaches.
Area of Science:
- Radiation Oncology
- Medical Physics
- Radiotherapy Technology
Background:
- Intensity modulated radiotherapy (IMRT) can be limited by multileaf collimator (MLC) maximum field size for large target volumes.
- Existing IMRT techniques may require specialized linear accelerator capabilities.
- Effective treatment of large targets necessitates advanced beam arrangement strategies.
Observation:
- A dual isocenter technique was developed, interlacing beams from two isocenters to maximize overlap.
- This interlaced technique was compared to a more complex 14-beam approach in a head-and-neck cancer case.
- Dosimetric and complexity analyses were performed, including assessment of isocenter translation errors.
Findings:
- The interlaced IMRT technique produced dose distributions nearly identical to the more complex method.
- The number of low monitor unit (MU) segments (
- The technique demonstrated robustness against isocenter translation errors up to +/-1 mm, with minimal dose point errors.
Implications:
- The dual isocenter interlaced IMRT technique offers a straightforward, versatile, and robust solution for treating large target volumes.
- This method is suitable for clinical routine, applicable across various anatomical regions, and does not rely on specific linear accelerator IMRT delivery systems.
- The technique simplifies treatment planning and delivery while maintaining high-quality dose distributions, addressing limitations of standard MLC-based IMRT.

